Concepedia

Patti Stampone

PS

Statistics

Publications

10

Citations

1.1K

H-Index

10

Active since

1997

Affiliations

3M (United States)(Current)

Patti Stampone is an author at 3M (United States) specializing in pharmacology, pharmacy, and pharmacotherapy.

Publications per year

1997–2006

10

Publications

10

Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies

John K. Geisse, Ivor Caro, Jane S. Lindholm et al. · Journal of the American Academy of Dermatology · 2004 · 505 citations

Medicine, Dermatology, Oncology +6

Clinically Important Improvements in Asthma-Specific Quality of Life, But No Difference in Conventional Clinical Indexes in Patients Changed From Conventional Beclomethasone Dipropionate to Approximately Half the Dose of Extrafine Beclomethasone Dipropionate

Elizabeth F. Juniper, David Price, Patti Stampone et al. · CHEST Journal · 2002 · 123 citations

Pharmacy, Pharmacology, Pharmacotherapy +6

Hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to chlorofluorocarbon beclomethasone dipropionate at approximately half the total daily dose

R.J. Davies, Patti Stampone, Brian O’Connor · Respiratory Medicine · 1998 · 113 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Categorizing Asthma Severity

Gene Colice, Jennifer Vanden Burgt, JESSIE SONG et al. · American Journal of Respiratory and Critical Care Medicine · 1999 · 95 citations

Pharmacy, Pharmacology, Pharmacotherapy +14

Recurrence rate of superficial basal cell carcinoma following successful treatment with imiquimod 5% cream: interim 2-year results from an ongoing 5-year follow-up study in Europe.

Harald Gollnick, Carlos Guillén Barona, Ronald G. Frank et al. · PubMed · 2006 · 76 citations

Medicine, Immunology, Pharmacology +14

1–5 of 10